Director's Dealing • Jul 10, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 4124F
Science in Sport PLC
10 July 2023
Science in Sport plc
("Company" or "Group")
Director/PDMR Shareholding
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following transaction by a PDMR.
Notification of a Transaction pursuant to Article 19(1) of the EU Market Abuse Regulation (EU) No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
1
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Lombard Odier Asset Management (Europe) Limited
2
Reason for notification
a.
Position/Status
PCA of Henry Turcan, Non-Executive Director
b.
Initial notification/
Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Science In Sport plc
b.
LEI
213800FWYWBJFJPPJ981
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument
Identification Code
Ordinary Shares of 10 pence each
GB00BBPV5329
b.
Nature of the transaction
Purchase of Ordinary Shares
c.
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.12 | 900,000 |
d.
Aggregated information
- Aggregated Volume
- Price
N/A
e.
Date of the transaction
4 July 2023
f.
Place of the transaction
Outside a trading venue
For further information, please contact:
| Science in Sport plc | T: 020 7400 3700 |
| Stephen Moon, CEO | |
| Dan Lampard, CFO | |
| Liberum (Nominated adviser and broker) | T: 020 3100 2000 |
| Richard Lindley Will Hall |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBIGDRIXGDGXR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.